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ABSTRACT
Osteoporosis is characterized by low bone mineral density (BMD) and fragility fracture and affects over 200 million people
worldwide. Bone quality describes the material properties that contribute to strength independently of BMD, and its quantitative
analysis is a major priority in osteoporosis research. Tissue mineralization is a fundamental process requiring calcium and phosphate
transporters. Here we identify impaired bone quality and strength in Slc20a2–/– mice lacking the phosphate transporter SLC20A2.
Juveniles had abnormal endochondral and intramembranous ossification, decreased mineral accrual, and short stature. Adults
exhibited only small reductions in bone mass and mineralization but a profound impairment of bone strength. Bone quality was
severely impaired in Slc20a2–/– mice: yield load (–2.3 SD), maximum load (–1.7 SD), and stiffness (–2.7 SD) were all below values
predicted from their bone mineral content as determined in a cohort of 320 wild-type controls. These studies identify Slc20a2 as a
physiological regulator of tissue mineralization and highlight its critical role in the determination of bone quality and strength. ©
2019 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
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Introduction
Osteoporosis is a common age-related disorder character-ized by low bone mineral density (BMD) and a loss of
structural integrity leading to an increased susceptibility to
fragility fracture. Osteoporosis affects over 200 million people
worldwide with over 9 million fractures occurring annually that
result in a massive and increasing healthcare burden.(1)
Although measurement of BMD by bone densitometry (DXA)
is a good predictor of fracture risk, it fails to account for the
effects of bone quality. Bone quality is the term used to describe
properties of bone composition and structure that contribute to
strength independently of BMD and it has emerged as an
important priority in osteoporosis research.(2) Thus, the material
properties and strength of the skeleton reflect contributions
from both bone quality and tissue mineralization.
Bone mineralization is a tightly regulated process involving
progressive mineralization of collagen fibrils secreted by bone-
forming osteoblasts. Although the mechanisms of apatite crystal
formation remain controversial, matrix vesicle (MV) budding
from the plasma membrane of mineralizing cells (osteoblasts or
mature chondrocytes) has been shown to create a nucleation
space for apatite crystals that deposit on collagen fibrils after MV
rupture.(3,4) This process requires that calcium (Ca) and
phosphate (Pi) transporters are expressed within MVs, whereas
obligatory expression of transporters at the cell surface is further
supported by the formation of transient intracellular amorphous
mineral precursors within mineralizing cells.(5) In mammals,
PiT1/SLC20A1 and PiT2/SLC20A2 are the major Pi transporters
expressed along with NPT2A in skeletal cells, and they are
thought to have a pivotal role in providing Pi for mineraliza-
tion.(6,7) Initial in vitro observations indicated that SLC20A1
expression was regulated by osteogenic factors,(8–13) suggesting
a specific role for SLC20A1 in skeletal mineralization.(10,14)
However, more recent in vivo approaches challenged this
hypothesis as (i) Slc20a1 hypomorphic adult mice had normal
bone mineralization,(15) (ii) chondrocyte-specific deletion (using
Col2a-Cre or Agc1-CreERT2 mice) of Slc20a1 revealed only subtle
or no bone abnormalities, respectively,(16,17) and (iii) SLC20A1
overexpression in rats did not affect bone mineralization.(18)
By contrast, identification of heterozygous pathogenic
variants in SLC20A2 that cause autosomal dominantly-inherited
primary familial brain calcification (PFBC; idiopathic basal
ganglia calcification [IBGC]) indicates a role for SLC20A2 in the
regulation of tissue mineralization. PFBC is characterized by
extensive brain calcification, predominantly localized to the
walls of cerebral microvessels.(19–21) This phenotype is recapitu-
lated in SLC20A2-deficient mice, in which a local increase in Pi
concentrations in the cerebrospinal fluid (CSF) has been
suggested to contribute to Ca-Pi deposition in CSF-producing
tissues and microvessels.(22,23) Preliminary histomorphometric
analysis of SLC20A2-deficient mice also suggested a role for
SLC20A2 in skeletal mineralization,(24) whereas SLC20A2 expres-
sion in vascular smooth muscle has been proposed to inhibit
vascular calcification.(25)
To determine the physiological role of SLC20A2 in tissue
mineralization, we performed detailed characterization of the
skeletal and dental phenotypes of SLC20A2-deficient mice.
These studies identify SLC20A2 as both a physiological regulator
of mineralization and an important determinant of bone quality
and strength in mice. To determine the physiological role of
SLC20A2 in tissue mineralization in humans we also evaluated
bone density in PFBC patients.
Materials and Methods
Mice
C57BL/6NTac-Slc20a2tm11a(EUCOMM)Wtsi (Slc20a2+/–) heterozygous
mice were obtained from the European Mouse Mutant Archive
(EMMA) and maintained and genotyped at the Wellcome Trust
Sanger Institute (WTSI) or Universite de Nantes. Further details
about the targeting construct are available at the website for the
International Mouse Phenotyping Consortium (IMPC; http://
www.mousephenotype.org/data/alleles/MGI:97851/tm1a
(EUCOMM)Wtsi). At Universite de Nantes, experiments on mice
were conducted according to the French and European
regulations on care and protection of laboratory animals (EC
Directive 86/609, French Law 2001-486 issued on June 6, 2001)
and to the NIH Office of Laboratory Animal Welfare (OLAW;
Project #02286.02). Animal care and maintenance were provided
through the Universite de Nantes accredited animal facility at
the “Unite de Therapeutique Experimentale.” Mice were fed with
RM1 for maintenance and with RM3 for breeding (Special Diets
Services [SDS], Essex, UK). To determine intact FGF23, phospho-
rus, calcium, and creatinine concentrations, mice were weaned
with 0.55% Pi and 0.70% Ca diets (Sniff Spezialdi€aten GmbH,
Soest, Germany). Slc20a2–/– mice were compared with hetero-
zygous or WT littermates. Mouse studies undertaken by Sanger
Mouse Pipelines as part of International Knockout Mouse (IKMC)
and IMPC Consortia were licensed by the UK Home Office in
accordance with the Animals (Scientific Procedures) Act 1986
and the recommendations of the Weatherall report. All mice
generated by Sanger Mouse Pipelines undergo a broad primary
phenotype screen (IMPC; http://www.mousephenotype.org)
that includes measurement of body length, X-ray skeletal
survey, DXA analysis of BMD, and biochemical measures of
mineral metabolism performed between 14 and 16 weeks of
age. Mice were fed Mouse Breeder Diet 5021 (Labdiet, London,
UK). Pipeline and husbandry details have been reported.(26,27)
Additional WT, Slc20a2+/–, and Slc20a2–/– mice were analyzed at
postnatal days P1, P16, P18, P21, P28, P35, P49, P98, P112, and
P224 (Supporting Fig. S1). Investigators were blinded to
genotype during all sample collections and sample processing:
genotypes were only assigned to individual samples for final
data analysis.
Serum and urine biochemistry
At P28, serum phosphate and calcium were analyzed using the
Phosphorus Liqui-UV Test and the Calcium CPC LiquiColor Test
kits according to the manufacturer’s protocol (Stanbio Labora-
tory, Boerne, TX, USA). Alkaline phosphatase (ALP) enzymatic
activity was measured from 2mL of serum using the ALP
Substrate kit (BioRad 172-1063; Bio-Rad Laboratories, Hercules,
CA, USA). Serum intact FGF23 concentrations were assessed
using an ELISA kit according to the manufacturer’s protocol
(Kainos Laboratories, Tokyo, Japan). At P112, serum phosphate,
calcium, and ALP were determined as part of the Sanger Mouse
Pipelines primary phenotype screen. Additional urine Pi, Ca, and
creatinine assays were performed with Olympus AU400
Chemistry Analyzer and serum intact FGF23 determined using
the Kainos Laboratories ELISA kit.
Skeletal and tooth preparations
Femurs from P1 mice and heads from P112 mice were isolated,
fixed in 4% paraformaldehyde for 24 to 48 hours and
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photographed using a Leica M125 binocular microscope (Leica
AG, Wetzlar, Germany) and Leica IC80 HD digital camera. Bone
lengths were determined digitally following linear calibration of
pixel size.
X-Gal staining
Organs dissected from postnatal mice were fixed for 30 to
120 min at room temperature in either 4% paraformaldehyde
(PFA) or 2% PFA and 0.2% glutaraldehyde in PBS. During
fixation, organs were cut in half after 30 min to improve
penetration of fixative and staining solutions. After fixation,
samples were rinsed with PBS and incubated overnight at
32°C in X-Gal staining solution (PBS containing 0.01% Tween
20, 2mM MgCl2, 4mM K4Fe(CN)6, 4mM K3Fe(CN)6, and 1 mg/mL
of X-gal; Invitrogen, La Jolla, CA, USA). Samples were postfixed
in 4% PFA and stored at 4°C. Images were acquired using a
M125 stereo-microscope (Leica) equipped with an IC80HD
camera (Leica). For histology, X-gal–stained skeletal samples
were decalcified in 0.5M EDTA (pH 8.0) at 4°C and embedded
in paraffin and cut at 7mm thickness using a Leica RM2255
microtome. Sections were counterstained with nuclear fast
red.
Whole mount stains
P1 mice were euthanized, fixed, and stored in 70% ethanol. Skin
and viscera were removed, and the intact skeleton stained with
Alizarin red and Alcian blue and stored in 100% glycerol.(28) Stained
P1 mice were imaged using a M125 stereo-microscope (Leica)
equipped with an IC80HD camera (Leica).
Histology
P21 limbs were fixed in 10% neutral buffered formalin for 24
hours and decalcified in 10% EDTA pH 7.4 for 14 days. 5-mm
paraffin-embedded sections were stained with Alcian blue and
van Gieson.(28) Images of the proximal tibia were acquired using
a Leica DM LB2 microscope and DFC320 digital camera.
Measurements at four locations across the width of growth
plates were obtained to calculate mean heights of the reserve,
proliferative, and hypertrophic zones, and total growth plate.
Results from two midline levels of sectioning were compared to
ensure data consistency. Reserve, proliferative, and hypertrophic
zone chondrocyte numbers were also determined in a 200-mm-
wide region at the center of the tibial growth plate section using
the Cell Counter Plugin in ImageJ 1.46 software (NIH, Bethesda,
MD, USA; https://imagej.nih.gov/ij/).
P16 femurs and P28, P112, and P224 heads were fixed in 4%
PFA for 24 to 72 hours, dehydrated in graded ethanol, and
embedded in methyl methacrylate resin (Technovit® 9100;
Kulzer GmbH, Wehrheim, Germany). Five-micrometer (5-mm)
undecalcified sections were cut using a hard tissue microtome
(Leica polycut SM 2500; Leica, Wetzlar, Germany), collected on
polylysine-coated slides and stained with Von Kossa(15) or
Movat’s pentachrome. P112 humeri were embedded in poly-
(methyl methacrylate) (PMMA). Five-micrometer (5-mm) midline
sagittal sections were cut using a Leica RM2265 microtome and
stained with von Kossa/Paragon.
Tibias used for immunohistochemistry (IHC) were fixed in 4%
PFA in PBS for 24 hours and decalcified in 0.5M EDTA before
embedding in paraffin (Leica TP1020 automated tissue proces-
sor). Four-micrometer (4-mm) serial sections were cut using a
Leica RM2255 microtome. Antigen retrieval conditions and
antibodies are reported in Supporting Table S1. Secondary anti-
mouse biotinylated goat antibody (1:500; DAKO, Carpinteria, CA,
USA) was used and staining performed using a diaminobenzi-
dine chromogen. Stained sections were mounted with Eukitt®
(Dutscher, France) and scanned using a Hamamatsu Nano-
Zoomer HT (Hamamatsu Photonics KK, Hamamatsu City, Japan)
digital scanner at magnification 20.
Digital X-ray microradiography
Soft tissue was removed and digital X-ray images recorded at 10
mm resolution using a Faxitron MX20 point projection X-ray
source and digital image system operating at 26 kV and 5
projective magnification (Qados, Cross Technologies Plc,
Sandhurst, UK). Bone mineral content (BMC) was determined
relative to steel, aluminum, and polyester standards and median
gray levels determined. Images were calibrated with a digital
micrometer and bone length determined as described.(28)
Micro–computed tomography
P112 long bones were analyzed by micro–computed tomogra-
phy (mCT) (Scanco mCT50; Scanco Medical AG, Br€uttisellen,
Switzerland) operating at 70 kV, 200mA, with a 0.5-mm
aluminum filter. Trabecular bone parameters (bone volume
[BV/TV], trabecular number [Tb.N], trabecular thickness [Tb.Th])
were determined at 3-mm resolution in a 1.5-mm region
beginning 100 mm proximal to the distal growth plate. Cortical
bone parameters (cortical thickness [Ct.Th], BMD, external
cortical diameter) were determined at 10mm voxel resolution
in a 1.5-mm region centered in the mid-shaft region 56% along
the length of the femur distal to the femoral head. Sixteen-bit
(16-bit) Digital Imaging and Communications in Medicine
(DICOM) images were imported using 32-bit Drishti v2.0.221
(National Computational Infrastructure, The Australian National
University, Acton, ACT, Australia; http://anusf.anu.edu.au/Vizlab/
drishti/) and rendered using 64-bit Drishti v2.0.000 to generate
high-resolution images.
P21 long bones were analyzed using a SkyScan-1272 X-ray
mCT system (Skyscan, Aartselaar, Belgium), operating at 50 kV
peak energy detection and 5 mm pixel resolution. Images were
reconstructed using Skyscan NRecon and CTVox softwares.
Heads of P28 and P224 WT and Slc20a2–/– mice were analyzed by
mCT (Skyscan 1272) at 50 kV and 173mA with a pixel size of 7mm.
Images were reconstructed using Skyscan NRecon and CTVox
software. 3D reconstruction of P49 mice were analyzed by mCT
(Skyscan 1072) at 50 kV and 200mA using a 0.5-mm aluminum
filter and a pixel size of 36mm.
Biomechanical testing
Humeri and caudal vertebrae (Ca6 and Ca7) were stored and
tested in 70% ethanol. Destructive three-point bend tests on
humeri and compression tests on vertebrae were performed
using an Instron 5543 load frame and 100-N or 500-N load cells
(Instron Limited, High Wycombe, Buckinghamshire, UK). Humeri
were positioned on custom supports and load was applied
perpendicular to the mid-diaphysis with a constant rate of
displacement of 0.03 mm/s until fracture. Vertebrae were bonded
in vertical alignment to a custom anvil support using cyanoacry-
late glue and load was applied vertically at a constant rate of
displacement of 0.03 mm/s and a sample rate of 20 Hz. Yield load,
maximum load, fracture load, and stiffness were determined from
load displacement curves.(29)
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Bone quality analysis
Correlation between BMC and biomechanical parameters was
determined by linear regression analysis using reference data,
updated every month, obtained from femur samples from 320
age- and sex-matched WT mice in an identical genetic
background. Femoral BMC (median gray level) correlated with
yield load (p¼ 0.005), maximum load (p< 0.00001), fracture load
(p¼ 0.00003), and stiffness (p¼ 0.003). Bone quality was
investigated in female mutant mice by comparing BMC and
observed biomechanical parameters in Slc20a2+/– and Slc20a2–/–
femurs with WT reference data.
Back-scattered electron–scanning electron microscopy
Femurs were fixed in 70% ethanol, opened longitudinally and
macerated.(28) Carbon-coated samples were imaged using back-
scattered electron–scanning electron microscopy (BSE-SEM) on a
Deben Gen5 BSE detector (Deben UK Ltd., Bury St Edmunds, UK)
and Tescan VEGA-3-XMU scanning electron microscope (Tescan-
UK Ltd., Cambridge, UK). High-resolution images were quantified
using ImageJ to determine the fraction of trabecular and
endosteal bone surfaces displaying osteoclastic resorption.(28)
Quantitative BSE-SEM
Neutral buffered formalin fixed humeri were embedded in
methacrylate. Longitudinal block faces were cut through
specimens, which were then polished, coated with carbon,
and analyzed using a Deben Gen5 BSE detector and Tescan
VEGA-3-XMU scanning electron microscope at 20 kV and 0.5 nA
with a working distance of 17 mm. BMDs were determined by
comparison to halogenated dimethacrylate standards, and an
eight-interval pseudocolor scheme was used to represent the
graduations of micromineralization.(28,30,31)
SEM
Technovit resin-embedded P28 and P224 head samples were
polished on a Metaserv 2000 (Buehler, Lake Bluff, IL, USA) and
P28 incisors were cryofractured. Samples were carbon-coated
on a Desk III (Denton Vacuum, Moorestown, NJ, USA) and
studied by backscattered SEM (Leo 1450 VP; Zeiss, Oberkochen,
Germany), at 20 kV.
Energy dispersive X-ray spectroscopy
Energy dispersive X-ray spectroscopy (EDX) analysis was
performed on P16 tibia and incisors and molars from P28 and
P224 mice as described.(15)
Osteoclast histomorphometry
Osteoclast numbers were determined according to the Ameri-
can Society for Bone and Mineral Research (ASBMR) system(31) in
paraffin sections from decalcified tibias stained for tartrate
resistant acid phosphatase (TRAP) activity, counterstained with
Aniline blue, and imaged using a Leica DMLB2 microscope and
DFC320 digital camera.(28) For each sample, sections from two
separate levels (n¼ 2 slides) were photographed at magnifica-
tion100 and a 1-mm 1-mm ROI commencing 250mm below
the growth plate was analyzed. Osteoclast numbers per bone
perimeter (Oc.N/B.Pm), osteoclast perimeter (Oc.Pm), and
osteoclast surface per bone perimeter (Oc.S/B.Pm) were
determined in trabecular bone and normalized to total bone
perimeter (B.Pm).(31) The fraction of bone surfaces that displayed
osteoclastic bone resorption was also quantified in high-
resolution BSE-SEM images.(28)
Dynamic histomorphometry of bone formation
2D parameters of bone formation were determined according to
the ASBMR.(31) Mice were given intraperitoneal injections of
calcein (10 mg/kg in 100mL PBS) 5 and 3 days prior to
euthanasia.(28) Midline longitudinal block faces were cut through
methacrylate-embedded long bones and calcein labels imaged
with a Leica SP5 confocal microscope at 488 nm excitation to
determine the fraction of bone surface undergoing active bone
formation.(28) Montages of 20 fields (magnification 40) were
constructed for each bone, and mineralizing surface (MS) and
mineral apposition rate (MAR) determined by quantifying calcein-
labeled surfaces and the mean separation between calcein
double labels using ImageJ. Bone formation rate (BFR) was
calculated by multiplying MS and MAR. Undecalcified proximal
humerus sections were also stained with von Kossa/Paragon to
determine the osteoid surface deposited as a fraction of total
bone perimeter (OS/B.Pm) and the osteoid thickness (O.Th).(32)
RNA isolation and RT-qPCR
Total RNA was prepared with TRIzol Reagent (ThermoFisher
Scientific, France), followed by Nucleospin RNA columns
(Macherey-Nagel, D€uren, Germany) (for calvaria, diaphysis,
and ribs) or using only Nucleospin RNA columns (for soft
tissues) according to the manufacturer’s instructions. Of total
RNA, 1 mg was reverse transcribed and analyzed using a Bio-Rad
CFX96 detection system using SYBR Select Master Mix (Applied
Biosystems, Warrington, UK). mRNA levels were normalized
relative to Tubulin, Glucuronidase, and/or Pinin expression and
quantified using the DDCT method.(33) RT-qPCR primers were
described(34,35) or are listed in Supporting Table S2.
Primary chondrocyte and osteoblast cultures
Primary rib chondrocytes were isolated from P7 mice as
described(36) and cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (ThermoFisher Scientific, France) supple-
mented with 10% FBS. At confluence, cells were plated as
described.(37) Cells were differentiated in DMEM supplemented
with 10% FBS, 100 IU/mL penicillin, 100mg/mL streptomycin,
50mg/mL of ascorbic acid, and 5mM b-glycerophosphate.
Primary calvarial osteoblasts were isolated from P6 mice and
cultured as described.(38) Cells were differentiated in aMEM
(Eurobio, France) supplemented with 10% FBS, 100 IU/mL
penicillin, 100mg/mL streptomycin, 50mg/mL of ascorbic acid,
and 5mM b-glycerophosphate. Mineralization was determined
by Alizarin Red S staining, and the area and size of mineralized
nodules were quantified using ImageJ.
Phosphate uptake measurements
Uptake of phosphate into primary chondrocytes and osteoblasts
was determined as described.(35)
Patients
Patients with SLC20A2 variants were identified as reported.(20)
Cranial non–contrast-enhanced CT scans were performed as
part of the routine PFBC diagnostic workup and DICOM images
were analyzed retrospectively. Age- and sex-matched controls
were randomly selected from CT scans performed in the Rouen
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University Hospital. Bone density was determined in right and
left occipital condyle spongiosa and parietal bone thickness was
determined 5 cm posterior to the coronal suture.
Statistics
Power calculations were performed to determine sample sizes
based on extensive prior experience and data obtained from our
high-throughput skeletal phenotype analysis(29) of >700
knockout mouse strains generated by the International
Knockout Mouse Consortium (IKMC). We determined coeffi-
cients of variation in >250 C57BL6/J WT mice for a comprehen-
sive set of skeletal phenotype parameters as follows: bone
length (2%); BMC by X-ray microradiography (2%); cortical bone
parameters by mCT (4% to 6%); trabecular bone parameters by
mCT (7% to 15%); bone mineralization by BSE-SEM (6%);
maximum load (9%); and fracture load (20%). Thus, a group
size of n¼ 4 is required for 90% power to detect a 20%
phenotype difference at a significance level of p< 0.05 when
using an analytical method with a coefficient of variation of 10%.
Data are shown as mean SE and were analyzed by ANOVA
followed by two-sided Tukey’s post hoc test or unpaired two-
sided Student’s t test as appropriate; p values <0.05 were
considered significant. Frequency distributions of mineralization
densities obtained by X-ray microradiography and quantitative
BSE (qBSE) were compared using the Kolmogorov-Smirnov test
in which p values for the D statistic in 1024-pixel data sets were
D¼>6.01 (p< 0.05), D¼>7.20 (p< 0.01), and D¼>8.62
(p< 0.001).
Results
Primary phenotype of Slc20a2–/– knockout mice
Slc20a2–/– knockout mice were generated as part of the IKMC
and IMPC at the Wellcome Trust Sanger Institute using a
knockout-first conditional ready targeting vector resulting in
mice harboring a reporter-tagged insertion allele (Slc20a2tm11a-
(EUCOMM)Wtsi) (Fig. 1A). A comprehensive summary of the
phenotype analysis performed is included in Supporting
Fig. S1. Homozygous Slc20a2–/– knockout mice had reduced
body length at postnatal day P98: Females 10.10cm (95% CI,
10.09 to 10.11cm; WT, n¼ 1460), 10.10cm (95% CI, 9.81 to
10.33cm; Slc20a2+/–, n¼ 7) and 9.64cm (95% CI, 9.42cm to
9.86cm; Slc20a2–/–, n¼ 7) (p< 0.001 versus WT or p< 0.05
versus Slc20a2+/–; Kruskal-Wallis test). Males 10.40cm (95% CI,
10.37cm to 10.39cm; WT, n¼ 1475), 10.55cm (95% CI, 10.24cm to
10.79cm; Slc20a2+/–, n¼ 6) and 9.70cm (95% CI, 9.60cm to
10.00cm; Slc20a2–/–, n¼ 7) (p< 0.001 versus WT or Slc20a2+/–;
Kruskal-Wallis test). Slc20a2–/– knockout mice also had reduced
body weight at birth: 1.486 0.196g (WT, n¼ 14),
1.490 0.244g (Slc20a2+/–, n¼ 31), and 1.286 0.166g
(Slc20a2–/–, n¼ 14) (p< 0.01 versus WT or Slc20a2+/–; Mann-
Whitney U test) that persisted until P116 (Fig. 1B). Female and
male homozygous Slc20a2–/– mice had low BMD at P98
compared to WT and heterozygous Slc20a2+/– littermates
(Fig. 1B; data not shown). X-ray microradiography and mCT
imaging of P21 and P112 skulls revealed lateral deviation of the
nasal bones and maxilla in 33% (8/24) of Slc20a2–/– mice (Fig. 1C;
Supporting Fig. S2), suggesting asymmetric and premature
fusion of the skull sutures. Accordingly, quantitative morpho-
metric analysis demonstrated marked decreases in multiple
cranial and dental morphological parameters in P112 Slc20a2–/–
mice compared to heterozygous and WT littermates (Supporting
Fig. 1. Continued.
Journal of Bone and Mineral Research SLC20A2: AN IMPORTANT GENETIC DETERMINANT OF BONE QUALITY AND STRENGTH 5
Fig. S2). Furthermore, P112 Slc20a2–/– mice had severe dental
fragility was evidenced by frequent incisor fractures (Fig. 1D). At
P224, Slc20a2–/– incisors exhibited an irregular yellow-brown
discoloration and chipping that further evidenced increased
fragility. mCT analysis of P224 male and female Slc20a2–/– mice
revealed brain calcification, which was confirmed in histological
sections from P112 Slc20a2–/–mice that revealed calcified lesions
within basal ganglia arterioles. Ectopic brain calcification was
accompanied by a markedly increased incidence of cataracts in
Slc20a2–/– mice (Fig. 1E). At P28, serum phosphate (Pi), calcium
(Ca), and fibroblast growth factor 23 (FGF23) levels were
unchanged in Slc20a2–/–mice (Fig. 1F). The urinary Ca/creatinine
ratio was normal in both female and male Slc20a2–/– mice,
whereas female Slc20a2–/– mice had an increased urinary Pi/
creatinine ratio an abnormality that had normalized by P112
(Supporting Fig. S3A). Serum ALP activity was increased in P28
Slc20a2–/– males (Fig. 1F) and in both males and females at P112
(Supporting Fig. S3A-B). This increase cannot be explained by
abnormal PTH(39) or vitamin D status (data not shown). Slc20a1
and Slc20a2mRNAs were expressed in similar tissues except for a
predominance of Slc20a1 in colon and cerebellum and Slc20a2 in
the heart. Both Slc20a1 and Slc20a2 were expressed in calvaria,
long-bone diaphysis, and rib cartilage (Fig. 2A). LacZ staining of
tissues from P18 Slc20a2–/– mice demonstrated expression in
blood vessels, cortical bone osteoblasts, and proliferating and
hypertrophic growth plate chondrocytes (Fig. 2B). LacZ staining
was also evident in several extraskeletal tissues, including
arteries within the brain, cerebellum, ovary, hair follicles, heart,
visceral adipose tissue, testis, and liver (Fig. 2C).
In summary, Slc20a2–/– mice recapitulate the phenotype of
symmetric calcification in the basal ganglia seen in PFBC, but
also have defective skeletal and dental development together
with abnormal tissue mineralization.
Decreased bone strength and quality in Slc20a2–/– mice
at P112
Biomechanical testing demonstrated profoundly decreased
bone strength and stiffness in adult Slc20a2–/– long bones
from both sexes (Fig. 3A, Supporting Fig. S4A) and decreased
strength in vertebrae from male Slc20a2–/– mice (Supporting
Fig. 1 Primary phenotype of Slc20a2–/– mice. (A) Slc20a2 knockout-first
conditional ready allele (reporter-tagged insertion allele). The gene-
trap knockout is generated using a targeting cassette containing lacZ
and neomycin marker genes. (B) mCT images of P49 female WT,
Slc20a2+/–, and Slc20a2–/– mice. Scale bar¼ 5 mm. Body length in
female and male WT, Slc20a2+/–, and Slc20a2–/– mice at P98 (medial
with interquartile range, n¼ 6 to 1474 per sex, per genotype, p< 0.05,
p< 0.001; Kruskal-Wallis test followed by Dunn’s post hoc test).
Body weight in female WT, Slc20a2+/–, and Slc20a2–/– mice between
P28 and P112 (mean SD, n¼ 6 to 34, per genotype per age, p< 0.05,
p< 0.01, p< 0.001, p< 0.0001 versus WT; ANOVA followed by
Tukey’s post hoc test). DXA BMD in female and male WT, Slc20a2+/–,
and Slc20a2–/– mice at P98 (median with interquartile range, n¼ 6 to
1469 per sex, per genotype, p< 0.05, p< 0.001; Kruskal-Wallis test
followed by Dunn’s post hoc test). (C) Apical mCT images of skulls from
P21 WT and Slc20a2–/– mice. Scale bar¼ 1 mm. Arrows indicate
abnormal nasal bones in Slc20a2–/– mice. (D) Images of incisors from
male and female P112 WT and Slc20a2–/– mice. Scale bars¼ 1 mm. (E)
Midline sagittal mCT images of skulls from WT and Slc20a2–/– mice at
P224. Scale bar¼ 1 mm. Low-power and high-power coronal sections
of the brain in Slc20a2–/– mice at P112; arrows indicate soft tissue
calcification. Scale bar¼ 100 mm. Images of the eye in WT and
Slc20a2–/– mice at P112 and the incidence of cataract. (F) Serum and
urinary calcium (Ca) and phosphate (Pi) and serum intact FGF23 and
ALP activity in female and male WT and Slc20a2–/– mice at P28
(mean SE, n¼ 3 to 14 per genotype per age, p< 0.01, p< 0.001
versus WT; Mann-Whitney U test).
Fig. 2. Primary phenotype of Slc20a2–/– mice. (A) Relative Slc20a1 and
Slc20a2 mRNA expression (mean SE) in skeletal and nonskeletal
tissues. Levels of Slc20a1 and Slc20a2mRNAs in tissues were determined
relative to expression in stomach after normalization toGusB and Tubulin
(n¼ 3). (B) LacZ expression from the Slc20a2tm11a(EUCOMM)Wtsi allele in rib
sections from P18 Slc20a2–/– mice: (a) skeletal muscle blood vessels; (b)
cortical bone; and (c) growth plate cartilage. (C) Lac Z expression in (i)
brain arteries, (ii) cerebellum, (iii) ovary, (iv) hair follicles, (v) heart, (vi)
adipose tissue, (vii) testis, and (viii) liver from P18 to P457 Slc20a2+/–
mice.
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Fig. 3. Decreased bone strength and stiffness in Slc20a2–/– mice. (A) Representative load displacement curves from three-point bend testing of humeri
from P112 WT, Slc20a2+/–, and Slc20a2–/– female mice showing yield load, maximum load, fracture load, and the gradient of the linear elastic phase
(stiffness). Graphs showing yield, maximum load, and fracture load, and stiffness (mean SE, n¼ 6, per genotype, p< 0.01, p< 0.001 versus WT;
ANOVA followed by Tukey’s post hoc test). (B) mCT images of the proximal tibial metaphysis and mid-diaphyseal tibial cortical bone from P112 WT,
Slc20a2+/–, and Slc20a2–/– female mice. Scale bar¼ 1 mm. (C) Graphs showing BV/TV, Tb.N, Tb.Th, Ct.Diameter, Ct.Th, and cortical BMD (mean SE, n¼ 6
per genotype, p< 0.05, p< 0.001, versus WT; ANOVA followed by Tukey’s post hoc test). (D) Representative BSE-SEM images of the distal femur from
P112 WT, Slc20a2+/–, and Slc20a2–/– mice. Scale bars¼ 1 mm (n¼ 4 to 5 per sex, per genotype). BV/TV¼ trabecular bone volume per tissue volume; Tb.
N¼ trabecular number; Tb.Th¼ trabecular thickness; Ct.Diameter¼ external cortical diameter; Ct.Th¼ cortical thickness.
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Fig. S5A). However, mCT structural analysis only revealed
decreases in some cortical and trabecular bone parameters in
adult Slc20a2–/– mice (Fig. 3B, C; Supporting Fig. S4B, C).
These observations were confirmed by BSE-SEM imaging of
macerated femurs (Fig. 3D, Supporting Fig. S4D). Further-
more, femur BMC was normal in female Slc20a2+/–
and Slc20a2–/– mice but decreased in males (Fig. 4A, B;
Supporting Fig. S6A, B). Vertebral BMC was also decreased
in both female and male Slc20a2–/– mice (Supporting
Fig. S5B, D).
Bone composition was thus analyzed by EDX. The Ca/Pi ratio
was increased in Slc20a2+/– and Slc20a2–/– mice (WT,
1.65 0.04; Slc20a2+/–, 1.83 0.04; Slc20a2–/–, 1.85 0.04),
demonstrating abnormal mineral composition in both hetero-
zygous and homozygous mutants (p< 0.05, p< 0.01, n¼ 4
to 7 per genotype, ANOVA followed by Tukey’s post hoc test).
Consistent with this, quantitative BSE-SEM (qBSE-SEM) analysis
at a sub-mm3-resolution scale demonstrated decreased tissue
mineralization in trabecular bone from female and male
Slc20a2+/– and Slc20a2–/– mice, and cortical bone from female
Slc20a2+/– and Slc20a2–/– mice and male Slc20a2–/– mice
(Fig. 4C, D; Supporting Fig. S6C, D). We next investigated bone
quality by comparing mineralization and biomechanical
parameters in femurs from female Slc20a2–/– mice with values
predicted by linear regression analysis of data from 320 femur
samples from age- and sex-matched WT mice on an identical
genetic background. Measures of bone quality in Slc20a2–/–
mice were abnormal, with yield load (–2.3 SD), maximum load
(–1.7 SD), and stiffness (–2.7 SD) all below WT predicted values
(Fig. 4E).
Overall, the profoundly impaired bone strength in adult
Slc20a2–/– mice resulted from abnormalities of bone quality,
composition, and mineralization.
Impaired postnatal skeletal development in Slc20a2–/–
mice
We first investigated skeletal development to determine the
mechanisms underlying the abnormalities of bone strength,
mineralization, and quality. Slc20a2–/– mice had delayed
formation of primary ossification centers compared to WT and
Slc20a2+/– littermates at P1 (Fig. 5A, B) followed by impaired
linear growth (Supporting Figs. S5B and D, S6B, and S7A and B).
The effects of Slc20a2 deletion on endochondral ossification
were investigated by histological analysis of the proximal tibia
growth plate. A 17% reduction in growth plate width,
predominantly affecting the reserve and hypertrophic zones,
was observed in P21 Slc20a2–/– mice (Fig. 5C, D). Nevertheless,
numbers of cells in each zone were similar among WT, Slc20a2+/–
and Slc20a2–/– mice, suggesting that chondrocyte volume and
hypertrophic chondrocyte enlargement are impaired in the
absence of Slc20a2 (Fig. 5D). Immunohistochemical staining of
type II and type X collagen confirmed the reduced width of the
Slc20a2–/– growth plate but demonstrated similar expression
patterns among the genotypes (Supporting Fig. S7C). Further-
more, no differences in expression of osteoblast and osteocyte
marker genes or genes involved in mineralization and Pi
transport were observed in Slc20a2–/– mice compared to WT
(Supporting Fig. S7D). Nevertheless, Von Kossa staining of
proximal tibia sections from Slc20a2–/– mice showed a 20%
decrease in cartilage mineralization compared to WT and
heterozygous littermates (Fig. 5E). Consistent with this, juvenile
Slc20a2–/–mice had decreased BMC in long bones and vertebrae
and decreases in trabecular and cortical bone parameters
Fig. 4. Continued.
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compared to WT and heterozygous mutants (Supporting
Fig. S7A, B; Supporting Table S3).
Overall, Slc20a2–/– mice exhibit defective endochondral
ossification resulting in impaired linear growth and skeletal
mineralization.
Impaired tooth development and mineralization in
Slc20a2–/– mice
Because of the high incidence of incisor fracture, we
investigated dental mineralization in juvenile and adult
Slc20a2–/– mice. mCT analysis demonstrated decreased incisor
and molar volumes in P28 Slc20a2–/– mice. Dentin and enamel
volumes were also reduced, and accompanied by an increased
pulp volume (Supporting Fig. S8A). Similar abnormalities were
also present in incisors from P224 mutants, likely due to the
continuous growth of rodent incisors (Fig. 6A). Movat’s
pentachrome staining demonstrated normal organization of
odontoblast and ameloblast palisades in Slc20a2–/– mice
(Fig. 6B; Supporting Fig. S8B). Nevertheless, there was a
marked increase in the unmineralized predentin layer and
reduction of the mineralized dentin layer in Slc20a2–/– mice,
indicating a mineralization defect consistent with the
increased pulp volume. SEM analysis demonstrated no differ-
ences in enamel structure in juvenile and adult Slc20a2–/–
mice. By contrast and consistent with our recent histological
studies,(40) dentin matrix morphology was abnormal with
irregular intertubular dentin, unfused calcospherites, and
increased interglobular spaces (Fig. 6C, Supporting Fig. S8C).
Finally, we determined enamel and dentin composition by
EDX. Consistent with the mineral composition abnormalities
identified in bone, the Ca/Pi ratio in Slc20a2–/– mice was also
increased in incisor enamel and mantle dentin at P28, and in
incisor mantle and circumpulpal dentin at P224 (Fig. 6D,
Supporting Fig. S8D).
Fig. 4 Decreased bone quality and micromineralization density in
Slc20a2–/– mice. (A) Quantitative X-ray microradiography images of
femurs from P112 WT, Slc20a2+/–, and Slc20a2–/– female mice. Scale
bars¼ 1 mm. Pseudocolored images represent grayscale images using
a 16-color interval scheme with low BMC in blue, and high BMC in red.
(B) Graph shows femur length (mean SE, n¼ 6 per genotype) and
relative frequency histogram shows relative BMC. (C) Representative
quantitative BSE-SEM images of proximal humerus trabecular bone and
humerus cortical bone from P112 WT, Slc20a2+/–, and Slc20a2–/– female
mice. Scale bars¼ 250 mm. Grayscale images were pseudocolored
using an eight-color interval scheme with low mineralization density in
blue and high mineralization density in red/pink. (D) Relative frequency
histograms of trabecular (left) and cortical (right) bone microminer-
alization densities (BMD) (n¼ 4 per genotype, p< 0.001 versus WT;
Kolmogorov-Smirnov test). (E) Bone quality analysis. Graphs demon-
strating the physiological relationship between relative bone mineral
content (median gray level determined by quantitative X-ray micro-
radiography) and yield load, maximum load, fracture load, and stiffness
in femurs from P112 female WT mice of identical genetic background
(n¼ 320). The line shows the linear regression and the gray box
indicates 2SD or 95% confidence intervals. Mean values for female
heterozygous Slc20a+/– mice are shown as orange circles and for
female homozygous Slc20a2–/– mice as pink circles; in data from 320
WT, BMC correlated significantly with yield load (p¼ 0.005), maximum
load (p< 0.00001), fracture load (p¼ 0.00003), and stiffness (p¼ 0.003).
Fig. 5. Impaired postnatal skeletal development in Slc20a2–/– mice. (A)
Forelimbs from P1 WT, Slc20a2+/–, and Slc20a2–/– mice stained with
Alizarin red (bone) and Alcian blue (cartilage). Scale bar¼ 1 mm. (B)
Forelimb digits stained with Alizarin red and Alcian blue. Scale
bar¼ 1 mm. Black arrows indicate delayed formation of primary
ossification centers in P1 Slc20a2+/– and Slc20a2–/– mice. (C) Decalcified
sections of proximal tibia from P21 WT, Slc20a2+/–, and Slc20a2–/– mice
stained with Alcian blue (cartilage) and van Gieson (bone matrix). Scale
bar¼ 100mm. (D) Upper left graph shows growth plate, RZ, PZ, and HZ
heights. Upper right graph shows relative values, where each zone is
shown as a percentage of total growth plate height (mean SE, n¼ 8
per genotype, p< 0.05, p< 0.001 versus height of zone in WT,
#p< 0.05, ##p< 0.01 versus total growth plate height in WT; ANOVA
followed by Tukey’s post hoc test). Lower left graph shows chondrocyte
cell number in RZ, PZ, and HZ. Lower right shows relative values, where
cell number in each zone is shown as a percentage of total cell number
(mean SEM, n¼ 8 per genotype). (E) Undecalcified sections of P16
proximal tibia stained with Von Kossa (mineral deposition in black). HZ
ROI is indicated by white rectangle. Scale bar¼ 100 mm. RZ¼ reserve
zone; PZ¼proliferating zone; HZ¼hypertrophic zone.
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Thus, even though tooth mineralization progresses in Slc20a2-
deficient mice, dentin mineralization and morphology remain
defective and teeth frequently fracture.
Bone resorption and formation in Slc20a2–/– mice
We next investigated osteoclastic bone resorption and osteo-
blastic bone formation to determine whether defects in bone
strength, mineralization, and quality resulted from abnormal
bone turnover. Histomorphometric analysis of osteoclast
parameters in proximal tibia sections and determination of
endosteal bone resorption by BSE-SEM demonstrated no
differences among WT, Slc20a2+/–, and Slc20a2–/–mice (Support-
ing Fig. S9A). Similarly, dynamic histomorphometry of bone
formation in calcein double-labeled specimens revealed no
differences between WT, Slc20a2+/–, and Slc20a2–/– mice
(Supporting Fig. S9B, C), and these findings were supported
by similar osteoid surfaces and thickness in all genotypes
(Supporting Fig. S9D).
We performed primary cell cultures to determine whether the
growth and mineralization abnormalities in Slc20a2–/– mice
resulted from intrinsic defects of chondrocyte or osteoblast
function. Absence of Slc20a2 mRNA expression was verified in
Slc20a2–/– cells by RT-qPCR a reduction of approximately 50%
was demonstrated in heterozygous cells (Supporting Fig. S10A,
B), confirming the Slc20a2tm11a(EUCOMM)Wtsi allele is null. As a
result, Naþ-Pi transport was reduced by 25% in Slc20a2-deficient
chondrocytes and by 75% in osteoblasts (Fig. 7A). Despite this,
no differences in expression of mature chondrocyte markers
(Col10a1, Runx2, Mmp13), mineralization regulatory genes (Alpl,
Phospho1) or the phosphate exporter Xpr1 were observed
(Supporting Fig. S10A) and in vitro mineralization of primary
chondrocytes from Slc20a2–/– mice did not differ from WT
(Fig. 7B). Similarly, no differences were observed during in vitro
differentiation (Supporting Fig. S10B), nodule formation, and
mineralization of primary calvarial osteoblasts from Slc20a2–/–
mice (Fig. 7C).
Fig. 6. Continued.
Fig. 6 Impaired tooth development and mineralization in Slc20a2–/–
mice. (A) Incisor (white bars) and first molar (black bars) mCT
parameters from P224 WT, Slc20a2+/–, and Slc20a2–/– male mice.
Graphs showing total tooth (Tooth vol), pulp (Pulp vol/tooth vol),
dentin (Dentin vol/tooth vol), and enamel (Enamel vol/tooth vol)
volumes relative to total tooth volume (mean SEM, n¼ 3 per
genotype, p< 0.0001, versus WT; two-way ANOVA followed by
Bonferroni post hoc test). (B) Low and higher power images of sagittal
sections of P224 mandibular incisors from WT and Slc20a2–/– male mice
stained with Movat. Scale bars¼ 50mm. Double arrows indicate
increased predentin thickness in Slc20a2–/– mice. Dotted lines indicate
decreased dentine thickness in Slc20a2–/– mice. (am¼ ameloblasts,
e¼ enamel, d¼dentin, od¼ odontoblasts, pd¼predentin). (C) SEM
images of enamel and dentin in resin-embedded mandibular incisors
form P224 WT and Slc20a2–/– male mice. Scale bars¼ 10 to 100mm.
White arrow indicates calcospherites in incisors of Slc20a2–/– mice.
White arrowhead indicates interglobular spaces in incisors of Slc20a2–/–
mice. (D) EDX analysis of incisors (white bars) and first molars (black
bars) from P224 WT, Slc20a2+/–, and Slc20a2–/– male mice. Graphs
showing calcium:phosphate ratio (Ca/P) in enamel (upper), mantle
dentin (middle), and circumpulpal (Pulp) dentin (lower) (mean SE,
n¼ 3 per genotype, p< 0.01; versus WT; two-way ANOVA followed by
Bonferroni post hoc test). EDX¼ energy-dispersive X-ray spectroscopy.
10 BECK-CORMIER ET AL. Journal of Bone and Mineral Research
These data demonstrate that Slc20a2 is essential for normal
phosphate transport, whereas chondrocyte and osteoblast
differentiation and mineralization were unaffected by deletion
of Slc20a2 in primary cultured cells.
Cranial mCT analysis of PFBC patients
Following the identification of major skeletal abnormalities in
Slc20a2–/– mice, we investigated PFBC patients with heterozy-
gous pathogenic variants in SLC20A2. A retrospective analysis
of medical records from a French series of PFBC patients(20)
revealed none of 24 had cataracts and 4 of 4 had normal
serum ALP concentrations. Average height was normal
(175.2 cm in males n¼ 10; 164.0 cm in females n¼ 5), although
one female had short stature (149.5 cm; –2.5 SD compared to
sex-specific normative values). No data were available
regarding tooth mineralization. One individual had suffered
a wrist fracture and two postmenopausal women had
osteopenia. Bone density and thickness in occipital condyle
and parietal bone spongiosa were determined in 21 patients
and age- and sex-matched controls using available CT data.
Mean bone density and thickness were decreased in PFBC
patients compared to controls (Fig. 8A, B).
Thus, preliminary analysis of PFBC patients with heterozygous
mutations in SLC20A2 suggests they may also have reduced
bone mass and mineralization.
Discussion
These studies show that Slc20a2 knockout mice have a
severely abnormal skeletal phenotype characterized by a
disproportionate reduction in bone strength that cannot be
accounted for by the modest reductions in cortical thickness
Fig. 8. Cranial mCT analysis of PFBC patients and normal control
individuals. (A) Bone density measurements in left and right OCs from
PFBC patients (n¼ 21) and matched controls (n¼ 22). (mean SE,
Student’s t test, p 0.01). (B) Left and right PB thickness measurements
in PFBC patients (n¼ 21) and matched controls (n¼ 22). (mean SE,
Student’s t test, p 0.01). OC¼ occipital condyle; PB¼parietal bone.
Fig. 7. Primary chondrocyte and osteoblast cultures. (A) Sodium-
dependent phosphate uptake in primary rib chondrocytes (left) or
calvarial osteoblasts (right) from WT and Slc20a2–/– mice (mean SE,
n¼ 4 to 7 per genotype, p< 0.01; versus WT; Mann-Whitney U test). (B)
Representative images of Alizarin red–stained high-density chondrocyte
pellets from P7 WT and Slc20a2–/–mice showing mineral deposition after
10 days in culture. Scale bars¼ 500 mm (n¼ 4 to 7 per genotype). Graph
shows quantitation of eluted Alizarin red stain. (C) Representative
images of Alizarin red–stained colony-forming calvarial osteoblasts from
P6 WT and Slc20a2–/– mice showing mineral deposition after 29 days in
culture. Scale bars¼ 500 mm (n¼ 3 per genotype). Graphs show
quantitation of eluted Alizarin red, fractional area of Alizarin red
staining, and mean size of mineralized nodules (mean SE, n¼ 3 per
genotype; Mann-Whitney U test).
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and BMC. Thus, SLC20A2-deficiency results in an important
functional impairment of bone quality characterized by an
increased calcium/phosphate ratio. Bone quality represents a
composite of interdependent factors that include both
structural and material parameters such as: bone geometry;
bone microarchitecture; the orientation and interrelationship
of matrix proteins and collagen fibrils; and hydroxyapatite
crystal size and packing, and has only recently been
appreciated as a major contributor to fracture risk.(2,41,42)
Here, we identify Slc20a2 as a new and important genetic
determinant of bone quality.
Slc20a2 knockout mice display a diverse disorder affecting
the skeleton, teeth, brain vasculature, and lenses that is due to
abnormal and/or inappropriate tissue mineralization. Extra-
skeletal abnormalities in Slc20a2 knockout mice recapitulate
the autosomal dominant human condition of PFBC character-
ized by symmetric calcification in the basal ganglia and other
brain regions in affected heterozygous individuals. However,
the major dental, skeletal, and ocular abnormalities reported
here were not recognized previously(24) and result from
complete SLC20A2 deficiency. Thus, SLC20A2 deficiency
causes abnormalities of endochondral and intramembranous
ossification that affect skeletal development, linear growth,
and mineral accrual, resulting in profound and discordant
decreases in bone strength and stiffness. Despite this, in
adults, SLC20A2 deficiency leads to only limited effects on
trabecular and cortical bone structure, turnover and minerali-
zation density.
Role of SLC20A2 in the determination of bone quality
In the MV-based model of mineralization, the nucleation of
apatite crystals from Ca and Pi ions occurs within the MV. In
this process Pi is provided from both intravesicular and
extravesicular sources.(14) The intravesicular Pi is generated by
PHOSPHO1, whereas the extravesicular Pi is thought to be
generated by tissue-nonspecific alkaline phosphatase (TNAP)
and transported into the MV via a Pi transporter that is yet to
be identified. Because SLC20A1 was shown to be regulated by
multiple osteogenic factors and to regulate proliferation,
differentiation and mineralization of chondrocytes or osteo-
blasts in vitro, it was long thought to be the responsible Pi
transporter. However, and consistent with the absence of a
mineralization defect of Slc20a1 hypomorphic mice,(15) we
showed that mineralization defects observed in the absence of
both PHOSPHO1 and SLC20A1 were not as severe as
abnormalities seen in the absence of PHOSPHO1 and TNAP,
further illustrating the minor role of Slc20a1 in matrix
mineralization.(16) Although it remains possible that SLC20A2
compensated for decreased expression of SLC20A1 in these
studies, the current studies suggest that apatite crystal
formation or nucleation still occurs in the absence of
SLC20A2. Current data are thus not consistent with an
essential role for SLC20A2 in providing Pi for initiation of
the mineralization process. Furthermore, because of the
emerging role for SLC20A1 in the skeleton and absence of
increased Slc20a1 expression in Slc20a2-deficient cells it is
unlikely that mineralization occurring in Slc20a2-deficient cells
results from functional compensation by SLC20A1. Neverthe-
less, functional compensation between SLC20A1 and SLC20A2
and a role for SLC20A2-mediated Pi transport, in determining
dental and bone material properties and quality require
further detailed investigation.
Systemic effects
The normal serum calcium, phosphate, FGF23, PTH, and 1,25(OH)
vitamin D(39) in Slc20a2–/– mice preclude a role for SLC20A2 in
systemic calcium and phosphate homeostasis. Nevertheless,
Slc20a2 knockout mice display placental dysfunction,(43) which
may contribute to delayed intrauterine endochondral ossification
and growth. This important developmental phenotype could be
further investigated by conditional deletion of Slc20a2 using
Mox2-Cre or Sox2-Cre mice.(44,45)
Growth plate and bone matrix effects
Similarly, systemic phosphate homeostasis cannot account for
the skeletal phenotype in Slc20a2–/– mice, indicating a critical
and local cell-intrinsic role for SLC20A2 in growth plate
chondrocytes and osteoblasts that is essential for linear
growth and the normal material properties of bone. Further-
more, the current studies demonstrate that Slc20a2–/–global
knockout mice have a contrasting skeletal phenotype to that
recently described in mice with inducible chondrocyte-specific
deletion of Slc20a1 (Slc20a1DAgc1/DAgc1).(17) In Slc20a1DAgc1/
DAgc1 mice, growth plate chondrocytes exhibited massive cell
death and endoplasmic reticulum (ER) stress whereas, in
Slc20a2–/– mice, growth plate chondrocytes are reduced in size
but not number resulting in impaired linear growth with no
evidence of cell death. By contrast, no bone abnormalities
were observed in Slc20a1DAgc1/DAgc1 mice, whereas Slc20a2–/–
global knockout mice have impaired bone strength and bone
quality. Thus, chondrocyte-specific deletion of Slc20a2 could
be used to determine the consequences of SLC20A2 deficiency
in the growth plate on adult bone material properties and
strength.
Dental effects
Systemic phosphate homeostasis cannot explain the dental
phenotype in Slc20a2–/– mice, thus, also indicating a critical and
local cell-intrinsic role for SLC20A2 in sub-odontoblastic cells.(40)
Importantly, we recently showed that Slc20a2 is also expressed
in lining sub-odontoblastic cells rather than in mineralizing
odontoblasts or ameloblasts, suggesting that SLC20A2 has a role
in mediating local crosstalk between mineralizing and non-
mineralizing cells that may involve functions other than Pi
transport.(40) Consistent with this, we have also shown that,
independently of its Pi transport function, SLC20A2 acts as a Pi-
sensor binding extracellular Pi and activating the ERK1/2 MAPK
signaling pathway and FGF23 secretion.(39,46) Therefore, dental
and skeletal mineralization and strength may involve a paracrine
role for SLC20A2 or an endocrine role in precisely regulating the
phosphate set point that is dependent on its Pi sensing capacity,
rather than Pi transport function.
Overall, our current data indicate that SLC20A1 and SLC20A2
possess common roles as phosphate transporters but exert
specific and non-redundant functions in cartilage and bone that
cannot be compensated for by each other. These studies further
suggest an important cell intrinsic role for SLC20A2 in the
skeleton.
SLC20A deficiency in humans
Preliminary analysis of available mCT data from a cohort of PFBC
patients identified abnormalities of cranial bone density and
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thickness, and these findings suggest that other skeletal and
dental abnormalities should be investigated. Furthermore,
findings of reduced bone mineralization in heterozygous
Slc20a2+/– mice (Fig. 4, Supporting Fig. S6) and a trend for a
gene dose effect on bone strength (Fig. 3, Supporting Figs. S4
and S5) suggest that careful consideration of fracture risk is
required in PFBC patients as it may be greater than that
predicted by BMD assessment given the profound effect on
bone quality observed in homozygous Slc20a2–/– mice (Fig. 4).
Nevertheless, future prospective studies that include (i) standard
DXA bone density measurements and (ii) multivariate analysis of
Fracture Risk Assessment Tool (FRAX) risk factors will be required
to establish the relationship between SLC20A2 deficiency and
BMD in PFBC patients.
Currently BMD is used as the key predictor of clinical
fracture risk but it fails to take account of bone quality
(https://www.sheffield.ac.uk/FRAX/). Accordingly, SLC20A2
was not identified as an independent locus associated with
BMD in the largest genomewide association study (GWAS) to
date.(47) Importantly, this GWAS only explains 12% of the
BMD phenotype variance and is unable to identify genetic
variants with predominant effects on bone quality. Never-
theless, the homologous skeletal Pi transporter SLC20A1
(PiT1) has recently been identified as the most significant
candidate gene in a GWAS of clinical vertebral fractures
independent of bone density,(48) further suggesting a critical
role for phosphate transport in the determination of bone
quality.
New approaches for bone quality analysis.
The challenge for the future will be to develop standards for
the assessment of bone quality. This will require validation of
novel methods that correlate in vitro and in vivo measures of
bone microarchitecture with bone strength and ductility. The
IMPC is generating knockout mice for all 20,000 protein
encoding genes on an identical genetic background and
provides a unique resource to facilitate identification of
genetic determinants of bone mass and strength(29,47) (Origins
of Bone and Cartilage Disease Project, London, UK; http://
www.boneandcartilage.com/). Here we extend this analysis to
identify defects of bone quality for the first time (Fig. 4). To
understand the molecular basis for abnormalities of bone
quality, our novel approach can now be combined with
analyses that determine the microstructural consequences of
gene deletion. Such methods will include Fourier transform
infrared microspectroscopy (FTIR),(49) multinuclear solid-state
nuclear magnetic resonance (NMR) spectroscopy, and powder
X-ray diffraction (XRD).(50)
In summary, we have shown that SLC20A2 deficiency results
in impaired bone quality and strength. Identification of further
genetic determinants of bone quality has the potential to lead
to a paradigm shift in bone biology. This will have implications
for the clinical assessment of fracture risk and for development
of novel therapeutic approaches that complement current
drugs, and which target bone turnover.
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